149 related articles for article (PubMed ID: 21294614)
21. Magnetic resonance imaging indicators for neurological outcome after surgery in patients with intramedullary spinal ependymomas.
Ma Y; Bai B; Zhao X; Wang L; Zhao B; Guo Y; Yin H; Zhang X; Zheng Z
Medicine (Baltimore); 2022 Jan; 101(4):e28682. PubMed ID: 35089217
[TBL] [Abstract][Full Text] [Related]
22. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.
Patronas NJ; Courcoutsakis N; Bromley CM; Katzman GL; MacCollin M; Parry DM
Radiology; 2001 Feb; 218(2):434-42. PubMed ID: 11161159
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and surgical outcomes of ependymomas in the upper cervical spinal cord: a single-center experience of 155 consecutive patients.
Fei X; Jia W; Gao H; Yang C; Li D; Qian Z; Han B; Wang D; Xu Y
Neurosurg Rev; 2021 Jun; 44(3):1665-1673. PubMed ID: 32767042
[TBL] [Abstract][Full Text] [Related]
26. Spinal tanycytic ependymoma associated with neurofibromatosis type 2--case report.
Ueki K; Sasaki T; Ishida T; Kirino T
Neurol Med Chir (Tokyo); 2001 Oct; 41(10):513-6. PubMed ID: 11760389
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of multisegmental intramedullary cervical spinal cord ependymomas].
Yang YM; Jiang HZ; Sha C; Yuan QG; Wang CC; Xie HW; Zhou K; Wang DM
Zhonghua Wai Ke Za Zhi; 2007 May; 45(10):705-7. PubMed ID: 17688827
[TBL] [Abstract][Full Text] [Related]
28. Tanycytic ependymoma in association with neurofibromatosis type 2.
Kobata H; Kuroiwa T; Isono N; Nagasawa S; Ohta T; Tsutsumi A
Clin Neuropathol; 2001; 20(3):93-100. PubMed ID: 11430494
[TBL] [Abstract][Full Text] [Related]
29. Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?
Dow G; Biggs N; Evans G; Gillespie J; Ramsden R; King A
J Neurosurg Spine; 2005 May; 2(5):574-9. PubMed ID: 15945431
[TBL] [Abstract][Full Text] [Related]
30. Intradural Extramedullary Primary Ependymoma of the Craniocervical Junction Combined with C1 Partial Agenesis: Case Report and Review of the Literature.
Morselli C; Ruggeri AG; Pichierri A; Marotta N; Anzidei M; Delfini R
World Neurosurg; 2015 Dec; 84(6):2076.e1-6. PubMed ID: 26210708
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
32. Intramedullary ependymoma of the spinal cord.
McCormick PC; Torres R; Post KD; Stein BM
J Neurosurg; 1990 Apr; 72(4):523-32. PubMed ID: 2319309
[TBL] [Abstract][Full Text] [Related]
33. Holocord ependymoma.
Gunes HF; Ozdemir N
Turk Neurosurg; 2012; 22(2):250-3. PubMed ID: 22437304
[TBL] [Abstract][Full Text] [Related]
34. Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery.
Sakai Y; Matsuyama Y; Katayama Y; Imagama S; Ito Z; Wakao N; Kanemura T; Yoshida G; Sato K; Ando T; Nakamura H; Kato F; Yukawa Y; Ito K; Ishiguro N
Spine (Phila Pa 1976); 2009 Jul; 34(15):1619-24. PubMed ID: 19564773
[TBL] [Abstract][Full Text] [Related]
35. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.
Birch BD; Johnson JP; Parsa A; Desai RD; Yoon JT; Lycette CA; Li YM; Bruce JN
Neurosurgery; 1996 Jul; 39(1):135-40. PubMed ID: 8805149
[TBL] [Abstract][Full Text] [Related]
36. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
37. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
38. Diffusion tensor imaging tractography in patients with intramedullary tumors: comparison with intraoperative findings and value for prediction of tumor resectability.
Setzer M; Murtagh RD; Murtagh FR; Eleraky M; Jain S; Marquardt G; Seifert V; Vrionis FD
J Neurosurg Spine; 2010 Sep; 13(3):371-80. PubMed ID: 20809733
[TBL] [Abstract][Full Text] [Related]
39. Bevacizumab as a surgery-sparing agent for spinal ependymoma in patients with neurofibromatosis type II: Systematic review and case.
Snyder MH; Ampie L; DiDomenico JD; Asthagiri AR
J Clin Neurosci; 2021 Apr; 86():79-84. PubMed ID: 33775351
[TBL] [Abstract][Full Text] [Related]
40. Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.
Safaee M; Parsa AT; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Tihan T; Ames CP
Neurosurg Focus; 2015 Aug; 39(2):E5. PubMed ID: 26235022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
